RxNorm Semantic Concepts Index - 603
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "603".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 603010 | sodium phosphate 1500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 603011 | sodium phosphate 1.5 GM Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 603011 | sodium phosphate 1.5 GM Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 603011 | sodium phosphate 1.5 GM Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603011 | sodium phosphate 1.5 GM Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 603019 | hyoscyamine / methenamine / methylene blue / phenyl salicylate Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 60307 | entacapone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 60307 | entacapone | Designated preferred name (PT) | YES | |
| RxCUI: 60307 | entacapone | Full form of descriptor (FN) | YES | |
| RxCUI: 60307 | entacapone | Designated preferred name (PT) | YES | |
| RxCUI: 60307 | entacapone | Full form of descriptor (FN) | YES | |
| RxCUI: 603086 | tobramycin 40 MG/ML Injectable Solution [Nebcin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603086 | tobramycin 40 MG/ML Injectable Solution [Nebcin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603086 | tobramycin 40 MG/ML Injectable Solution [Nebcin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603103 | naproxen 375 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603103 | naproxen 375 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603103 | naproxen 375 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 603103 | naproxen 375 MG Delayed Release Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 603103 | naproxen 375 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 603110 | lanthanum carbonate 1000 MG [Fosrenol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603112 | FOSRENOL 1000 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603112 | FOSRENOL 1000 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603112 | FOSRENOL 1000 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603116 | lanthanum carbonate 250 MG [Fosrenol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603117 | lanthanum carbonate 250 MG Chewable Tablet [Fosrenol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603117 | lanthanum carbonate 250 MG Chewable Tablet [Fosrenol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603121 | lanthanum carbonate 750 MG [Fosrenol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603122 | FOSRENOL 750 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603122 | FOSRENOL 750 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603122 | FOSRENOL 750 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603136 | acetaminophen 325 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603136 | acetaminophen 325 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 603136 | acetaminophen 325 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603139 | acetaminophen 500 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 603139 | acetaminophen 500 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 603139 | acetaminophen 500 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603159 | Rozerem | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603160 | ramelteon 8 MG [Rozerem] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603161 | ramelteon Oral Tablet [Rozerem] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603162 | Rozerem 8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603162 | Rozerem 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603162 | Rozerem 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603177 | Cypex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603182 | hyoscyamine Oral Tablet [Ed Spaz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603202 | erlotinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 603203 | erlotinib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 603203 | erlotinib 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603203 | erlotinib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603203 | erlotinib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 603203 | erlotinib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 603205 | erlotinib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 603206 | erlotinib 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 603206 | erlotinib 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603206 | erlotinib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603206 | erlotinib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 603206 | erlotinib 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 603207 | erlotinib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 603208 | erlotinib 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 603208 | erlotinib 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603208 | erlotinib 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603208 | erlotinib 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 603208 | erlotinib 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 603225 | chlorpheniramine / methscopolamine Extended Release Oral Tablet [Ryneze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603256 | Sudafed PE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603258 | phenylephrine Oral Tablet [Sudafed PE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603273 | Sudogest PE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603275 | phenylephrine Oral Tablet [Sudogest PE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603281 | UROCIT-K 10 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603281 | UROCIT-K 10 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603281 | UROCIT-K 10 MEQ Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603281 | UROCIT-K 10 MEQ Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603281 | UROCIT-K 10 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603282 | UROCIT-K 5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603282 | UROCIT-K 5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603282 | UROCIT-K 5 MEQ Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603282 | UROCIT-K 5 MEQ Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603282 | UROCIT-K 5 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603285 | Mi-Acid Gas Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603286 | simethicone 80 MG [Mi-Acid Gas Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603287 | simethicone Chewable Tablet [Mi-Acid Gas Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603288 | Mi-Acid Gas Relief 80 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603288 | Mi-Acid Gas Relief 80 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603288 | Mi-Acid Gas Relief 80 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 6033 | Ile - Isoleucine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6033 | Ile - Isoleucine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6033 | Ile - Isoleucine | Designated preferred name (PT) | YES | |
| RxCUI: 6033 | Ile - Isoleucine | Full form of descriptor (FN) | YES | |
| RxCUI: 6033 | Ile - Isoleucine | Designated preferred name (PT) | YES | |
| RxCUI: 6033 | Ile - Isoleucine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6033 | Ile - Isoleucine | Full form of descriptor (FN) | YES | |
| RxCUI: 60331 | CA 549 - Carbohydrate antigen 549 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60331 | CA 549 - Carbohydrate antigen 549 | Designated preferred name (PT) | NO | |
| RxCUI: 60331 | CA 549 - Carbohydrate antigen 549 | Full form of descriptor (FN) | NO | |
| RxCUI: 60331 | CA 549 - Carbohydrate antigen 549 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603326 | Uni-Guaifen 600/300 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603330 | zinc gluconate Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603331 | zinc gluconate 50 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 603338 | fexofenadine / pseudoephedrine Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 60334 | risedronate sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 60334 | risedronate sodium | Designated preferred name (PT) | YES | |
| RxCUI: 60334 | risedronate sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 60335 | Transin 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60335 | Transin 2 | Designated preferred name (PT) | NO | |
| RxCUI: 60335 | Transin 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 60335 | Transin 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603376 | tipranavir 250 MG [Aptivus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603377 | tipranavir Oral Capsule [Aptivus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603378 | Aptivus 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603378 | Aptivus 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603378 | Aptivus 250 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603386 | psyllium Oral Capsule [Konsyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 6034 | Isoleucyl-tRNA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6034 | Isoleucyl-tRNA synthetase | Full form of descriptor (FN) | NO | |
| RxCUI: 6034 | Isoleucyl-tRNA synthetase | Designated preferred name (PT) | NO | |
| RxCUI: 6034 | Isoleucyl-tRNA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60343 | Hepatitis C antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60343 | Hepatitis C antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60343 | Hepatitis C antibody | Designated preferred name (PT) | NO | |
| RxCUI: 60343 | Hepatitis C antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 60343 | Hepatitis C antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60343 | Hepatitis C antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60344 | PUMP-1 | Designated preferred name (PT) | NO | |
| RxCUI: 60344 | PUMP-1 | Full form of descriptor (FN) | NO | |
| RxCUI: 60344 | PUMP-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60344 | PUMP-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6035 | Brachiose | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6035 | Brachiose | Designated preferred name (PT) | NO | |
| RxCUI: 6035 | Brachiose | Full form of descriptor (FN) | NO | |
| RxCUI: 603534 | NexIUM I.V. 20 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603534 | NexIUM I.V. 20 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 603534 | NexIUM I.V. 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603534 | NexIUM I.V. 20 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 603534 | NexIUM I.V. 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 603534 | NexIUM I.V. 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603534 | NexIUM I.V. 20 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 603536 | NexIUM I.V. 40 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603536 | NexIUM I.V. 40 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 603536 | NexIUM I.V. 40 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603536 | NexIUM I.V. 40 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 603536 | NexIUM I.V. 40 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603536 | NexIUM I.V. 40 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603536 | NexIUM I.V. 40 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 603539 | natalizumab 20 MG/ML [Tysabri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603541 | Tysabri 300 MG in 15 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603541 | Tysabri 300 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603541 | Tysabri 300 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603541 | Tysabri 300 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603554 | pseudoephedrine Extended Release Oral Tablet [Sudafed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603564 | nelarabine 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 603565 | nelarabine Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603566 | nelarabine 250 MG in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 603566 | nelarabine 250 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603566 | nelarabine 250 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603566 | nelarabine 250 MG in 50 ML Injection | Designated preferred name (PT) | YES | |
| RxCUI: 603566 | nelarabine 250 MG in 50 ML Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 603571 | Human Albumin Grifols | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603572 | albumin human, USP 200 MG/ML [Human Albumin Grifols] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603577 | albumin human, USP 250 MG/ML [Human Albumin Grifols] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603589 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML / phenylephrine tannate 2.5 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 603599 | brompheniramine / dextromethorphan / phenylephrine Extended Release Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603642 | carbetapentane tannate 6 MG/mL / phenylephrine tannate 1 MG/mL / pyrilamine tannate 6 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 603642 | carbetapentane tannate 6 MG/mL / phenylephrine tannate 1 MG/mL / pyrilamine tannate 6 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 603643 | C-Tanna 12D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603645 | carbetapentane / phenylephrine / pyrilamine Oral Suspension [C-Tanna 12D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603646 | carbetapentane tannate 6 MG/ML / phenylephrine tannate 1 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [C-Tanna 12D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603646 | carbetapentane tannate 6 MG/ML / phenylephrine tannate 1 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [C-Tanna 12D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603655 | carbinoxamine / dextromethorphan / pseudoephedrine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603697 | carbetapentane / diphenhydramine / phenylephrine Extended Release Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603697 | carbetapentane / diphenhydramine / phenylephrine Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 603699 | Dytan-CS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603701 | carbetapentane / diphenhydramine / phenylephrine Extended Release Suspension [Dytan-CS] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603701 | carbetapentane / diphenhydramine / phenylephrine Extended Release Suspension [Dytan-CS] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 603703 | diphenhydramine / hydrocodone / phenylephrine Extended Release Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603703 | diphenhydramine / hydrocodone / phenylephrine Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 603705 | Dytan-HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603707 | diphenhydramine / hydrocodone / phenylephrine Extended Release Suspension [Dytan-HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603707 | diphenhydramine / hydrocodone / phenylephrine Extended Release Suspension [Dytan-HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 603710 | carbetapentane / phenylephrine Extended Release Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603711 | carbetapentane tannate 30 MG / phenylephrine tannate 30 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603711 | carbetapentane tannate 30 MG / phenylephrine tannate 30 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 603723 | acetaminophen Oral Suspension [Mapap] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603724 | Mapap Childrens 160 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603724 | Mapap Childrens 160 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603724 | Mapap Childrens 160 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603724 | Mapap Childrens 160 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603724 | Mapap Childrens 160 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603737 | carbetapentane / pseudoephedrine Extended Release Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 603738 | carbetapentane citrate 1.5 MG/ML / pseudoephedrine HCl 6 MG/ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603738 | carbetapentane citrate 1.5 MG/ML / pseudoephedrine HCl 6 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 603746 | urea 65 MG/ML [carbamide peroxide otic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603747 | urea Otic Solution [carbamide peroxide otic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603748 | urea 65 MG/ML Otic Solution [carbamide peroxide otic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603748 | urea 65 MG/ML Otic Solution [carbamide peroxide otic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603749 | fluocinolone Otic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 603754 | hydrocortisone / neomycin / polymyxin B Otic Suspension [Otic Ear Care] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603755 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension [Otic Ear Care] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603755 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension [Otic Ear Care] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603755 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension [Otic Ear Care] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603771 | sodium chloride Nasal Gel [ENTsol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603777 | flunisolide 0.029 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 603779 | flunisolide 0.029 MG/ACTUAT [Nasarel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603782 | vitamin B12 Nasal Spray [Nascobal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603797 | hydrocortisone 0.0055 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 603799 | hydrocortisone / lidocaine Rectal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Designated preferred name (PT) | YES | |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Full form of descriptor (FN) | YES | |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Designated preferred name (PT) | YES | |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6038 | Isonicotinic acid hydrazide | Full form of descriptor (FN) | YES | |
| RxCUI: 603803 | phenylephrine / shark liver oil Rectal Cream [Formulation R] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603807 | Tannate 12 S | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603809 | carbetapentane / chlorpheniramine Oral Suspension [Tannate 12 S] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603813 | Tannihist-12D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603815 | carbetapentane / phenylephrine / pyrilamine Oral Suspension [Tannihist-12D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603816 | carbetapentane tannate 6 MG/ML / phenylephrine tannate 1 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [Tannihist-12D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603816 | carbetapentane tannate 6 MG/ML / phenylephrine tannate 1 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [Tannihist-12D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603823 | Ron Acid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603824 | magaldrate 108 MG/ML [Ron Acid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603825 | magaldrate Oral Suspension [Ron Acid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603826 | magaldrate 108 MG/ML Oral Suspension [Ron Acid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603826 | magaldrate 108 MG/ML Oral Suspension [Ron Acid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603826 | magaldrate 108 MG/ML Oral Suspension [Ron Acid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603832 | fenofibrate 160 MG [Lofibra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603833 | fenofibrate Oral Tablet [Lofibra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603834 | Lofibra 160 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603834 | Lofibra 160 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 603834 | Lofibra 160 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603835 | fenofibrate 54 MG [Lofibra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603836 | Lofibra 54 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603836 | Lofibra 54 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 603836 | Lofibra 54 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603842 | meloxicam 1.5 MG/ML [Mobic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603843 | meloxicam Oral Suspension [Mobic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603844 | Mobic 7.5 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603844 | Mobic 7.5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603844 | Mobic 7.5 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 603844 | Mobic 7.5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603879 | brompheniramine tannate 4 MG / carbetapentane tannate 30 MG / phenylephrine tannate 7.5 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 603879 | brompheniramine tannate 4 MG / carbetapentane tannate 30 MG / phenylephrine tannate 7.5 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603899 | Altacaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603901 | tetracaine Ophthalmic Solution [Altacaine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603917 | Altazine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603919 | tetrahydrozoline Ophthalmic Solution [Altazine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 60392 | Gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603922 | docusate Enema [Docusol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603926 | Medicone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603927 | benzocaine 0.2 MG/MG [Medicone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603928 | benzocaine Rectal Ointment [Medicone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603929 | Medicone 20 % Rectal Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603929 | Medicone 20 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603929 | Medicone 20 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603930 | Tucks Suppositories | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603931 | starch 0.51 MG/MG [Tucks Suppositories] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603932 | starch Rectal Suppository [Tucks Suppositories] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603933 | Tucks Internal Soothers 51 % Rectal Suppository | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603933 | Tucks Internal Soothers 51 % Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 603933 | Tucks Internal Soothers 51 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603933 | Tucks Internal Soothers 51 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603952 | Proctocare-HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 603953 | hydrocortisone 25 MG/ML [Proctocare-HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 603954 | hydrocortisone Rectal Cream [Proctocare-HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 603955 | hydrocortisone 25 MG/ML Rectal Cream [Proctocare-HC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 603955 | hydrocortisone 25 MG/ML Rectal Cream [Proctocare-HC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 603955 | hydrocortisone 25 MG/ML Rectal Cream [Proctocare-HC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60397 | n-perfluorooctane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60397 | n-perfluorooctane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60397 | n-perfluorooctane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 60397 | n-perfluorooctane | Designated preferred name (PT) | NO | |
| RxCUI: 60397 | n-perfluorooctane | Full form of descriptor (FN) | NO | |
| RxCUI: 60397 | n-perfluorooctane | Designated preferred name (PT) | NO | |
| RxCUI: 60397 | n-perfluorooctane | Full form of descriptor (FN) | NO | |
| RxCUI: 603976 | nepafenac 1 MG/ML [Nevanac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 603977 | nepafenac Ophthalmic Suspension [Nevanac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 603978 | Nevanac 0.1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 603978 | Nevanac 0.1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 603978 | Nevanac 0.1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603978 | Nevanac 0.1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 603989 | Tetravisc | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 603991 | tetracaine Ophthalmic Solution [Tetravisc] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |